- Rating
- 2
- Confidence
- 2
- Informativeness
- 1
- Presentation
- 2
- Soundness
- 2
Read review
Paper summary
This paper proposes ApexMO, an framework to generate, filter, and refine peptide. ApexMo adopts a length-conditioned discrete flow matching model to generate 63,000 proposals. Then an anchor selection algorithm to filter and select 500 anchor candidates. A Refinementi algorithm iteratively refine the selectaed anchors. Finally, a screen algorithm ranks and clusters to have the 25 candidates.
In the experiemnt, the paper benchmarks 3 different generation algorithm, flow matching, AMP-Diffusion, and ARCADIAMP in generation quality and generation throughput. Then it evaluate the MIC predictor performance. The paper finaly benchmarks the pareto refinement improvement and the edit budget constraints.
Critical strengths
-
The general idea of generate -> anchor select -> Refine -> ranking is an interesting pipeline. This looks to me can be extended into a framework for drug discovery.
-
Comparing different generation algorithm provides an informative perspective to the community. It shows that flow matching balances the throughput and quality.
Critical weaknesses
The motivation of certain components in the pipelien of this paper remains unclear to me.
-
Why budget constraint refinement is necessary. Since the process is completely in silico, it does not makes sense to me to save budget in this process.
-
The second and third research questions are not specific and deep. For instance, "does constrained multi-objective selection improve the final population relative to matched local-search controls?" This looks to me can be universally applied to any objective-condition generation task. So it is important to explain why this research is important. What we can learn from studying this research question. Similar argument can be applied to the third research question.
-
The method section lacks a high-level explanation to the proposed workflow (figure 1). I found it hard to understand the bigger picture and background of this section. Tons of notations lacks definition and explanation, such as f(x) in Eq. 1. Is it a energy function or loss to minimze? Similarly what is B(L) in Eq 2?
-
The paper mentions the flow matching model is condifitoned on peptide length but did not mention how to achieve this or cite any paper.
-
The refinement process is a mixing of insertion, substituting, and replacing in a random manner. This looks very brutal force and lacks insignt? For instance, there is no explanation for replacing glutamic acid into Leucine (Figure 4). However, scientis perform such replace for a certain reason, i.e., increasing half life.
Questions for authors
Please refer to my weakness section. In the rebuttal, I would like to see more discussion in motivation and the justification of the key research questions.